null - FindTrial

N/A - N/A

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2052260022

Enrollment

250

Registered

2026-04-14

Start date

2026-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symptomatic severe tricuspid regurgitation TR

Interventions

Interventional tricuspid valve repair

TriClip

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)The patient must be eligible to receive the TriClip System per the current approved indications for use, and 2)The patient must provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care. If informed consent is not obtained, the subject is excluded from the post-approval study (recruitment failure).

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
(1) Moderate or less TR at 30-day visit. (2) Single leaflet device attachment (SLDA) at 30-day visit.	—

Contacts

Public ContactEtsuro Okamoto

Abbott Medical Japan

etsuro.okamoto@abbott.com+81-76-434-2315

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026